Substance for Dentin Hypersensitivity Treatment - ANVISA Registration 80231319008
Access comprehensive regulatory information for Substance for Dentin Hypersensitivity Treatment in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 80231319008 and manufactured by LABORATORIOS KIN S.A.. The registration is held by PHARMAKIN COMERCIO DE COSMETICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including PHS DO BRASIL LTDA, BRAVI INDUSTRIA E COMERCIO DE PRODUTOS ODONTOLOGICOS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80231319008
25351684573201780
05046637000132
Company Information
Dates and Status
Apr 16, 2018
VIGENTE
09/18/2025 19:00:01
PHS DO BRASIL LTDAโข Brazil
BRAVI INDUSTRIA E COMERCIO DE PRODUTOS ODONTOLOGICOS S.A.โข Brazil
ULTRADENT PRODUCTS INCโข United States of America
ULTRADENT DO BRASIL PRODUTOS ODONTOLรGICOS LTDAโข Brazil
DENTSCARE LTDAโข Brazil
Subst.P/Tratamento Hipersensibilidade Dentinaria
Remineral SensiHAPair
JHS LABORATORIO QUIMICO LTDA
80149989002
Aug 04, 2025
Subst.P/Tratamento Hipersensibilidade Dentinaria
DESSENSIBILIZANTE S.S.WHITE
S S WHITE ARTIGOS DENTARIOS S/A
80149719058
Jan 13, 2025
Subst.P/Tratamento Hipersensibilidade Dentinaria
Bliss Desense
YLLER BIOMATERIAIS S.A.
81009350028
Jan 13, 2025
Subst.P/Tratamento Hipersensibilidade Dentinaria
Desensy
DMC IMPORTACAO E EXPORTACAO DE EQUIPAMENTOS LTDA.
80030810187
Dec 16, 2024
Subst.P/Tratamento Hipersensibilidade Dentinaria
DESSENSIBILIZANTE DENTAL - TOP PRIME
BRAVI INDUSTRIA E COMERCIO DE PRODUTOS ODONTOLOGICOS S.A.
80929710043
Dec 02, 2024

